Lilly Endowment Is First to Hit $100 Billion Mark on Stock Surge
Eli Lilly & Co.’s stock has reached new highs in recent days, becoming the first pharmaceutical company to hit a $1 trillion valuation. The surge has also lifted the founding...
By Biz Carson · Bloomberg Markets
Eli Lilly & Co.’s stock has reached new highs in recent days, becoming the first pharmaceutical company to hit a $1 trillion valuation. The surge has also lifted the founding family’s private foundation to a record $100 billion in assets.